Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04352166Phase 2Completed
Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder
Opioid-use Disorder
PrincipalinvestigatorStart date: 2020-12-15
NCT00141115Phase 2Completed
Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
AlcoholismAnxiety DisordersGeneralized Anxiety Disorder+2 more
Principalinvestigator
NCT00217971Phase 2Completed
Dronabinol Treatment for Marijuana Addiction
Marijuana Abuse
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yair bAR-hAIM, PhD

Tel Aviv University

Related
18 trials

Shared therapeutic areas:

Phobia, SocialAnxiety DisordersGeneralized Anxiety Disorder
Similarity Score13%

Sabine Wilhelm, PhD

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

Phobia, SocialGeneralized Anxiety DisorderPanic Disorder
Similarity Score13%

Gerhard Andersson, Professor

Linkoeping University

Related
12 trials

Shared therapeutic areas:

Generalized Anxiety DisorderPhobia, SocialAnxiety Disorders
Similarity Score13%

Metin ÇınaroÄŸlu, Phd

Istanbul Nisantasi University

Related
9 trials

Shared therapeutic areas:

Anxiety DisordersGeneralized Anxiety DisorderAlcoholism
Similarity Score13%

Daniel S Pine, M.D.

National Institute of Mental Health (NIMH)

Related
10 trials

Shared therapeutic areas:

Anxiety DisordersPanic Disorder
Similarity Score9%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Generalized Anxiety DisorderAnxiety Disorders
Similarity Score9%

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

Opioid Use DisorderAnxiety Disorders
Similarity Score9%

Murray B Stein, MD, MPH

University of California, San Diego

Related
8 trials

Shared therapeutic areas:

Anxiety DisordersPhobia, Social
Similarity Score9%

Rajita Sinha, PhD

Yale University

Related
11 trials

Shared therapeutic areas:

AlcoholismOpioid Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score9%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

AlcoholismAnxiety Disorders
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04352166Phase 2PrincipalInvestigator

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use Disorder
Completed
NCT00141115Phase 2PrincipalInvestigator

Levetiracetam for the Treatment of Alcohol Dependence and Anxiety

AlcoholismAnxiety DisordersGeneralized Anxiety Disorder+2 more
Completed
NCT00217971Phase 2PrincipalInvestigator

Dronabinol Treatment for Marijuana Addiction

Marijuana Abuse
Completed

All 3 trials loaded